Preclinical News and Research

RSS
Entry inhibitors can provide first new hepatitis B & D treatments for many years

Entry inhibitors can provide first new hepatitis B & D treatments for many years

2 Apr 2011
Experts must monitor new antiviral compounds for HCV treatment

Experts must monitor new antiviral compounds for HCV treatment

2 Apr 2011
Pfizer to present new investigational compounds data against cancer at AACR meeting

Pfizer to present new investigational compounds data against cancer at AACR meeting

2 Apr 2011
Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

2 Apr 2011
PBI commits to sponsor APS Novel Disease Model Awards for 2011 through 2013

PBI commits to sponsor APS Novel Disease Model Awards for 2011 through 2013

2 Apr 2011
Champions enters exclusive license agreement with BCCA for Irinophore C

Champions enters exclusive license agreement with BCCA for Irinophore C

2 Apr 2011
Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

1 Apr 2011
Neogenix Oncology to present laboratory studies of NEO-101 at AACR Annual Meeting

Neogenix Oncology to present laboratory studies of NEO-101 at AACR Annual Meeting

1 Apr 2011
Study shows immune therapy can prevent pregnancy in mammals including humans

Study shows immune therapy can prevent pregnancy in mammals including humans

1 Apr 2011
VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

1 Apr 2011
Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

31 Mar 2011
Immune therapy can control fertility in mammals

Immune therapy can control fertility in mammals

31 Mar 2011
RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals to acquire Apthera

31 Mar 2011
Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

31 Mar 2011
Researchers identify drug candidate that can treat prostate cancer

Researchers identify drug candidate that can treat prostate cancer

31 Mar 2011
Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

31 Mar 2011
Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

31 Mar 2011
Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

31 Mar 2011
FDA grants orphan drug status to America Stem Cell's ASC-101

FDA grants orphan drug status to America Stem Cell's ASC-101

30 Mar 2011
SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

30 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback